One study that assessed the DNA of 77 MS patients and 95 healthy controls identified Bsm I and Apa I polymorphisms of the VDR gene showed that the AA genotype and the [A] allele were significantly more prevalent in MS patients than in controls, suggesting increased risk [83]. This evidence concerns the gene VDR and myeloid sarcoma.